Tade, Danny Boy L.

HRN: 23-13-05  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2024
ALBENDAZOLE 400MG (TAB)
07/03/2024
08/03/2024
PO
400mg
BID
Neurocystercicosis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Central Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: